Elanco Closes in on IPO
Eli Lilly spin-off Elanco Animal Health has amended its filing with the SEC regarding its initial public offering.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 124
Are Some Cancer Treatments Becoming Too Expensive to Approve?
The topic of acceptable costs versus acceptable results is one that may never have a final conclusion in which everyone agrees.
Why Akcea and Ionis Are Getting Crushed
Akcea and Ionis were each crushed on Tuesday after the firms announced that they received a Complete Response Letter from the FDA.
Why Affimed Shares More Than Doubled
Affimed shares more than doubled early on Tuesday after it was announced that the firm entered into a strategic collaboration agreement with Genentech.
Ra Medical Closes in on IPO
Commercial-stage medical device company Ra Medical Systems has amended its filing with the SEC for its initial public offering.
Pfizer Slips Despite Strong Late-Stage Results
Pfizer shares slipped on Monday despite the company posting positive results from a late-stage tafamidis trial.
Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks
The August 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks was mixed.
Short Sellers Run for Cover From Major Biotechs
The August 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
The Safest Level of Drinking Alcohol: None
Results of a new study on the effects of alcohol use conclude that the safest level of drinking is none. Alcohol use, the researchers say, contributes to health loss from many causes and exacts…
Kala Pharma Sees Unexpected Reaction to FDA Approval
Kala Pharmaceuticals shares dipped on Thursday after the U.S. Food and Drug Administration (FDA) announced that it had approved INVELTYS (loteprednol etabonate ophthalmic suspension) 1% for the treatment of post-operative inflammation and pain following…
Valeritas Gears Up For Secondary Offering
Diabetes-focused medtech company Valeritas has filed with the SEC regarding its initial public offering.
7 Biotech Stocks Insiders Are Loading Up On
La Jolla Pharmaceutical and Sarepta Therapeutics are among seven biotech stocks that have seen some notable insider trading recently.
Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018
Big Pharma is looking good for investors in the second half of 2018. That's the message from the research team at Bank of America Merrill Lynch.
How the FDA Is Fighting the Nationwide EpiPen Shortage
The FDA is extending the expiration dates for certain EpiPens in light of the national shortage ahead of the back-to-school season.
Why Premier Is Tuesday’s Big Earnings Winner
Premier shares soared after it reported its fiscal fourth-quarter results before the markets opened on Tuesday.